| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| bendamustine rituximab follicular lymphoma | 0.34 | 0.2 | 9082 | 59 | 42 |
| bendamustine | 1.65 | 0.4 | 4287 | 37 | 12 |
| rituximab | 1.35 | 0.7 | 4332 | 59 | 9 |
| follicular | 0.75 | 0.9 | 2934 | 68 | 10 |
| lymphoma | 0.27 | 0.6 | 5204 | 78 | 8 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| bendamustine rituximab follicular lymphoma | 0.25 | 0.7 | 7938 | 32 |
| follicular lymphoma bendamustine and rituxan | 1.23 | 0.5 | 4764 | 79 |
| bendamustine and rituximab for lymphoma | 1.38 | 0.8 | 3634 | 46 |
| bendamustine rituximab mantle cell lymphoma | 0.21 | 0.9 | 2696 | 49 |
| bendamustine and rituxan for lymphoma | 1.97 | 0.3 | 4319 | 92 |
| bendamustine obinutuzumab follicular lymphoma | 1.95 | 0.3 | 8368 | 60 |
| bendamustine and rituximab for cll | 1.79 | 1 | 7303 | 79 |
| rituximab lenalidomide follicular lymphoma | 1.71 | 0.4 | 3090 | 29 |
| rituximab for follicular lymphoma | 0.4 | 1 | 4269 | 52 |
| follicular lymphoma rituximab monotherapy | 0.19 | 0.5 | 2692 | 41 |
| follicular lymphoma maintenance rituximab | 0.82 | 0.2 | 7582 | 45 |
| single agent rituximab follicular lymphoma | 0.52 | 0.4 | 8231 | 21 |
| indolent follicular lymphoma rituximab | 1.62 | 0.4 | 7000 | 84 |
| bendamustine and rituximab protocol | 1.87 | 1 | 1693 | 99 |
| rituximab and bendamustine treatment | 1.65 | 0.9 | 1235 | 76 |
| rituximab and bendamustine regimen | 1.36 | 0.7 | 7976 | 2 |
| fiche patient rituximab bendamustine | 1.76 | 0.5 | 2685 | 52 |
| bendamustine and rituximab macmillan | 0.95 | 0.8 | 4569 | 3 |
